122 related articles for article (PubMed ID: 16117838)
1. Molecular therapeutic targets in rheumatoid arthritis.
Sacre SM; Andreakos E; Taylor P; Feldmann M; Foxwell BM
Expert Rev Mol Med; 2005 Aug; 7(16):1-20. PubMed ID: 16117838
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of rheumatoid arthritis: targeting cytokines.
Zwerina J; Redlich K; Schett G; Smolen JS
Ann N Y Acad Sci; 2005 Jun; 1051():716-29. PubMed ID: 16127012
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. Cytokine networks--towards new therapies for rheumatoid arthritis.
McInnes IB; Liew FY
Nat Clin Pract Rheumatol; 2005 Nov; 1(1):31-9. PubMed ID: 16932625
[TBL] [Abstract][Full Text] [Related]
5. Emerging cytokine targets in rheumatoid arthritis.
Asquith DL; McInnes IB
Curr Opin Rheumatol; 2007 May; 19(3):246-51. PubMed ID: 17414950
[TBL] [Abstract][Full Text] [Related]
6. Joint inflammation and cytokine inhibition in rheumatoid arthritis.
Christodoulou C; Choy EH
Clin Exp Med; 2006 Mar; 6(1):13-9. PubMed ID: 16550339
[TBL] [Abstract][Full Text] [Related]
7. Tumour necrosis factor-alpha as a new therapeutic target for rheumatoid arthritis: an update.
Giasuddin AS; Hoque ME; Ahmed ZU
Bangladesh Med Res Counc Bull; 2005 Dec; 31(3):88-94. PubMed ID: 17549869
[TBL] [Abstract][Full Text] [Related]
8. Treatment of rheumatoid arthritis in the 21st century: targeting B-lymphocytes.
Brezinschek HP; Brickmann K; Yazdani-Biuki B; Dörner T; Graninger WB; Brezinschek RI
Wien Med Wochenschr; 2006 Jan; 156(1-2):61-7. PubMed ID: 16465615
[TBL] [Abstract][Full Text] [Related]
9. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.
Williams RO; Paleolog E; Feldmann M
Curr Opin Pharmacol; 2007 Aug; 7(4):412-7. PubMed ID: 17627887
[TBL] [Abstract][Full Text] [Related]
10. Emerging therapeutics for rheumatoid arthritis.
Bingham CO
Bull NYU Hosp Jt Dis; 2008; 66(3):210-5. PubMed ID: 18937634
[TBL] [Abstract][Full Text] [Related]
11. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
Takasugi K; Yamamura M; Iwahashi M; Otsuka F; Yamana J; Sunahori K; Kawashima M; Yamada M; Makino H
Arthritis Res Ther; 2006; 8(4):R126. PubMed ID: 16859503
[TBL] [Abstract][Full Text] [Related]
12. Emerging targets of biologic therapies for rheumatoid arthritis.
Tarner IH; Müller-Ladner U; Gay S
Nat Clin Pract Rheumatol; 2007 Jun; 3(6):336-45. PubMed ID: 17538565
[TBL] [Abstract][Full Text] [Related]
13. Update on cytokines in rheumatoid arthritis.
Brennan F; Beech J
Curr Opin Rheumatol; 2007 May; 19(3):296-301. PubMed ID: 17414959
[TBL] [Abstract][Full Text] [Related]
14. Immunological therapies for rheumatoid arthritis.
Edwards CJ
Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791
[TBL] [Abstract][Full Text] [Related]
15. [Destruction of articular cartilage].
Koike T
Clin Calcium; 2006 Sep; 16(9):1543-47. PubMed ID: 16951481
[TBL] [Abstract][Full Text] [Related]
16. Novel therapeutic targets in rheumatoid arthritis.
Koenders MI; van den Berg WB
Trends Pharmacol Sci; 2015 Apr; 36(4):189-95. PubMed ID: 25732812
[TBL] [Abstract][Full Text] [Related]
17. Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor.
Ernestam S; af Klint E; Catrina AI; Sundberg E; Engström M; Klareskog L; Ulfgren AK
Arthritis Res Ther; 2006; 8(1):R18. PubMed ID: 16507118
[TBL] [Abstract][Full Text] [Related]
18. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of biologicals in the treatment of rheumatoid arthritis. a meta-analysis.
Venkateshan SP; Sidhu S; Malhotra S; Pandhi P
Pharmacology; 2009; 83(1):1-9. PubMed ID: 18957873
[TBL] [Abstract][Full Text] [Related]
20. A review of the action of tacrolimus (FK506) on experimental models of rheumatoid arthritis.
Miyata S; Ohkubo Y; Mutoh S
Inflamm Res; 2005 Jan; 54(1):1-9. PubMed ID: 15723198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
